Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1014, Copenhagen, Denmark.
Department of Pathology, Odense University Hospital, J. B. Winsløws Vej 15, 5000, Odense, Denmark.
BMC Cancer. 2017 Dec 28;17(1):897. doi: 10.1186/s12885-017-3929-6.
In Denmark, national roll-out of a population-based, screening mammography program took place in 2007-2010. We report on outcome of the first four biennial invitation rounds.
Data on screening outcome were retrieved from the 2015 and 2016 national screening quality reports. We calculated coverage by examination; participation after invitation; detection-, interval cancer- and false-positive rates; cancer characteristics; sensitivity and specificity, for Denmark and for the five regions.
At the national level coverage by examination remained at 75-77%; lower in the Capital Region than in the rest of Denmrk. Detection rate was slightly below 1% at first screen, 0.6% at subsequent screens, and one region had some fluctuation over time. Ductal carcinoma in situ (DCIS) constituted 13-14% of screen-detected cancers. In subsequent rounds, 80% of screen-detected invasive cancers were node negative and 40% ≤10 mm. False-positive rate was around 2%; higher for North Denmark Region than for the rest of Denmark. Three out of 10 breast cancers in screened women were diagnosed as interval cancers.
High coverage by examination and low interval cancer rate are required for screening to decrease breast cancer mortality. Two pioneer local screening programs starting in the 1990s were followed by a decrease in breast cancer mortality of 22-25%. Coverage by examination and interval cancer rate of the national program were on the favorable side of values from the pioneer programs. It appears that the implementation of a national screening program in Denmark has been successful, though regional variations need further evaluation to assure optimization of the program.
丹麦于 2007-2010 年开展了一项基于人群的筛查乳腺摄影计划。我们报告了前四轮双年度邀请的结果。
我们从 2015 年和 2016 年的国家筛查质量报告中检索了筛查结果数据。我们计算了丹麦和五个地区的检查覆盖率;邀请后的参与率;检出率、间隔期癌和假阳性率;癌症特征;敏感性和特异性。
在国家层面,检查覆盖率保持在 75-77%;首都大区低于丹麦其他地区。首次筛查的检出率略低于 1%,随后的筛查为 0.6%,一个地区的检出率随时间略有波动。导管原位癌(DCIS)占筛查发现癌症的 13-14%。在随后的几轮中,80%的筛查发现的浸润性癌症为淋巴结阴性,40%≤10mm。假阳性率约为 2%;北丹麦地区高于丹麦其他地区。筛查女性中三分之一的乳腺癌被诊断为间隔期癌。
为了降低乳腺癌死亡率,筛查需要高的检查覆盖率和低的间隔期癌发生率。两个 20 世纪 90 年代开始的先驱性局部筛查项目之后,乳腺癌死亡率下降了 22-25%。该国家计划的检查覆盖率和间隔期癌发生率处于先驱计划的有利数值范围之内。丹麦全国性筛查计划的实施似乎取得了成功,尽管区域差异需要进一步评估,以确保计划的优化。